TMCNet:  Liberator Medical Reports Revenue of $17.6 Million for Its First Fiscal Quarter Ended December 31, 2012

[February 14, 2013]

Liberator Medical Reports Revenue of $17.6 Million for Its First Fiscal Quarter Ended December 31, 2012

(Marketwire Via Acquire Media NewsEdge) STUART, FL -- (Marketwire) -- 02/14/13 -- Liberator Medical Holdings, Inc. (OTCBB: LBMH) today announced the financial results for its first fiscal quarter ended December 31, 2012. Sales for the quarter ended December 31, 2012 increased by $2,755,000, or 18.6%, to $17,551,000, compared with sales of $14,796,000 for the quarter ended December 31, 2011. The increase in sales was due to the Company's continued direct response advertising campaign to acquire new customers and strong reorder rates from its recurring customer base during the last quarter of the calendar year. Liberator's direct response advertising expenditure for the quarter ended December 31, 2012, was $2.8 million, compared with $2.7 million for the quarter ended December 31, 2011.


First Fiscal Quarter 2013 Financial Highlights Revenue of $17.6 million, an increase of 18.6% over the last year's first quarter Operating margins increased to 12.9% of sales compared with 5.3% a year ago Net income of $1.4 million, or $0.03 per share, compared with net income of $0.5 million, or $0.01 per share, for the first quarter last year  Cash generated from operations of $1.4 million, an increase of $3.3 million compared with cash used in operations of $1.9 million for the first quarter last year As of December 31, 2012, the Company had $4.4 million of cash and $4.7 million available from its credit line facility. Income from operations for the quarter ended December 31, 2012, increased by $1,479,000, or 189.9%, to $2,258,000, compared with the quarter ended December 31, 2011. The increase in operating income is primarily attributed to increased gross profits driven by our increased sales volumes as well as a reduction as a percentage of sales in operating expenses.

Mark Libratore, the Company's President and CEO, commented, "We are very pleased with our financial performance for the first quarter. We increased sales by 19% over last year at higher operating margins and generated $1.4 million in operating cash flows for the quarter. We will continue to manage the levels of our direct response advertising spend to maximize profitability and cash flows for fiscal year 2013. Based on investments we have made in our employees, infrastructure, and technology, we expect to continue to increase our operating margins and cash flows for fiscal year 2013 compared with fiscal year 2012." Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com About Liberator Medical Holdings, Inc.

Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Providerâ„¢ accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, personal mobility aids, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

Safe Harbor Statement Certain statements in this press release that are not historical, but are forward-looking, are subject to known and unknown risks and uncertainties which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this press release. Such risks and uncertainties may include, but are not limited to, the Company's need to raise equity capital and its ability to obtain equity financing on acceptable terms, if at all, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, the risk of early obsolescence of our products and the other factors listed under "Risks and Uncertainties" in our annual report on Form 10-K for the fiscal year ended September 30, 2008 and our other filings with the Securities and Exchange Commission. We assume no obligation to update the information contained in this news release.

Liberator Medical Holdings, Inc. and Subsidiaries Condensed Consolidated Balance Sheets As of December 31, 2012 (unaudited) and September 30, 2012 (In thousands, except dollar per share amounts) December September 31, 30, 2012 2012 -------- ---------- Assets Current Assets: Cash $ 4,431 $ 3,326 Accounts receivable, net of allowances of $5,022 and $5,044, respectively 9,200 10,365 Inventory, net of allowance for obsolete inventory of $362 and $310, respectively 2,426 2,627 Deferred taxes, current portion 2,310 2,254 Prepaid and other current assets 346 287 -------- ---------- Total Current Assets 18,713 18,859 Property and equipment, net of accumulated depreciation of $3,035 and $2,888, respectively 1,411 1,250 Deferred advertising 23,032 22,426 Intangible assets, net of accumulated amortization of $107 and $91, respectively 223 239 Other assets 87 88 -------- ---------- Total Assets $ 43,466 $ 42,862 ======== ========== Liabilities and Stockholders' Equity Current Liabilities: Accounts payable $ 4,525 $ 6,537 Accrued liabilities 1,608 1,221 Other current liabilities 96 92 -------- ---------- Total Current Liabilities 6,229 7,850 Deferred tax liability 6,283 5,421 Credit line facility 2,500 2,500 Other long-term liabilities 114 132 -------- ---------- Total Liabilities 15,126 15,903 -------- ---------- Stockholders' Equity: Common stock, $.001 par value, 200,000 shares authorized, 48,266 and 48,232 shares issued, respectively; 48,177 and 48,143 shares outstanding at December 31, 2012, and September 30, 2012, respectively 48 48 Additional paid-in capital 34,736 34,707 Accumulated deficit (6,394) (7,746) Treasury stock, at cost; 89 shares at December 31, 2012, and September 30, 2012 (50) (50) -------- ---------- Total Stockholders' Equity 28,340 26,959 -------- ---------- Total Liabilities and Stockholders' Equity $ 43,466 $ 42,862 ======== ========== See accompanying notes to unaudited condensed consolidated financial statements.

Liberator Medical Holdings, Inc. and Subsidiaries Condensed Consolidated Statements of Operations For the three months ended December 31, 2012 and 2011 (Unaudited) (in thousands, except per share amounts) Three Months Ended December 31, -------------------- 2012 2011 --------- --------- Sales $ 17,551 $ 14,796 Cost of Sales 6,573 6,003 --------- --------- Gross Profit 10,978 8,793 --------- --------- Operating Expenses Payroll, taxes and benefits 3,843 3,464 Advertising 2,203 1,968 Bad debts 1,278 1,130 Depreciation and amortization 164 199 General and administrative 1,232 1,253 --------- --------- Total Operating Expenses 8,720 8,014 --------- --------- Income from Operations 2,258 779 --------- --------- Other Expense Interest expense (21) (12) --------- --------- Total Other Expense (21) (12) --------- --------- Income before Income Taxes 2,237 767 Provision for Income Taxes 885 313 --------- --------- Net Income $ 1,352 $ 454 ========= ========= Basic earnings per share: Weighted average shares outstanding 48,147 48,057 Earnings per share $ 0.03 $ 0.01 Diluted earnings per share: Weighted average shares outstanding 52,143 52,321 Earnings per share $ 0.03 $ 0.01 See accompanying notes to unaudited condensed consolidated financial statements.

Liberator Medical Holdings, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows For the three months ended December 31, 2012 and 2011 (Unaudited) (in thousands) Three Months Ended December 31, ------------------ 2012 2011 -------- -------- Cash flow from operating activities: Net Income $ 1,352 $ 454 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 2,310 2,123 Equity based compensation 10 38 Provision for doubtful accounts and contractual adjustments 1,335 1,163 Deferred income taxes 805 307 Reserve for inventory obsolescence 53 6 Changes in operating assets and liabilities: Accounts receivable (169) (2,449) Deferred advertising (2,753) (2,700) Inventory 148 119 Other assets (57) (175) Accounts payable (2,013) (945) Accrued liabilities 393 142 Other liabilities 3 (27) -------- -------- Net Cash Flow Provided by (Used in) Operating Activities 1,417 (1,944) -------- -------- Cash flow from investing activities: Purchase of property and equipment (308) (40) Net Cash Flow Used in Investing Activities (308) (40) -------- -------- Cash flow from financing activities: Proceeds from employee stock purchase plan 13 20 Proceeds from credit line facility - 1,000 Payments of debt and capital lease obligations (17) (7) -------- -------- Net Cash Flow Provided by (Used in) Financing Activities (4) 1,013 -------- -------- Net increase (decrease) in cash 1,105 (971) Cash at beginning of period 3,326 3,016 -------- -------- Cash at end of period $ 4,431 $ 2,045 ======== ======== Supplemental disclosure of cash flow information: Cash paid for interest $ 21 $ 12 Cash paid for income taxes $ 5 $ - Supplemental schedule of non-cash investing and financing activities: Capital expenditures funded by capital lease borrowing $ - $ 18 See accompanying notes to unaudited condensed consolidated financial statements.

Contacts:Individual Investor Relations ContactWSR Communications772-219-7525IR@WSRcommunications.comhttp://wsrcommunications.ir.stockpr.com/liberatormedical Institutional Investor ContactLyn DavisLittlebanc Advisors, LLC561-948-3005ld@littlebanc.comwww.littlebanc.com Source: Liberator Medical Holdings, Inc.

[ Back To Cloud Computing 's Homepage ]